CryoPort, Inc. (CYRX) Earnings Call Analysis
NASDAQ · Industrials · Integrated Freight & Logistics
Next earnings call: 2026-08-06
(Q2 2026)
— full calendar
Earnings Reports
-
CryoPort (CYRX) Q1 2026: Commercial Cell & Gene Therapy Revenue Jumps 26% as Pipeline Matures
May 05, 2026
-
Cryoport (CYRX) Q4 2025: Commercial Cell & Gene Therapy Revenue Surges 29%, Anchoring Long-Term Growth
March 04, 2026
-
Cryoport (CYRX) Q3 2025: Cell & Gene Therapy Revenue Climbs 36% as Commercial Pipeline Expands
November 05, 2025
-
Cryoport (CYRX) Q2 2025: Service Revenue Climbs 21% as DHL Partnership Recasts Global Reach
August 06, 2025
-
Cryoport (CYRX) Q1 2025: Life Sciences Services Now 56% of Revenue as DHL Deal Reshapes Strategic Focus
July 04, 2025